Weinrich S, Sarna L
Department of Administrative and Clinical Nursing, College of Nursing, University of South Carolina, Columbia 29208.
Cancer. 1994 Oct 1;74(7 Suppl):2079-91. doi: 10.1002/1097-0142(19941001)74:7+<2079::aid-cncr2820741716>3.0.co;2-0.
Delirium occurs in 25-40% of patients with cancer and in as many as 85% of patients with advanced cancer. Delirium, or acute confusion, can be short term and reversible and differs from dementia, which is chronic and irreversible. Accurate assessment is critical for effective treatment and to reduce the increased mortality associated with delirium. Assessment for differentiating depression as well as dementia is needed, because mistaken diagnoses often prolong and exacerbate the symptoms of delirium. Different treatment strategies are appropriate depending on the cause(s) of confusion. In this article, risk factors and assessment tools are reviewed, and interventions for delirium in older persons with cancer are presented. Future areas for research are identified, because there is a paucity of research on delirium in older patients with cancer.
谵妄发生在25%至40%的癌症患者中，在多达85%的晚期癌症患者中也会出现。谵妄，即急性意识模糊，可能是短期且可逆的，与慢性且不可逆的痴呆症不同。准确评估对于有效治疗以及降低与谵妄相关的死亡率至关重要。需要进行评估以区分抑郁症和痴呆症，因为误诊往往会延长和加重谵妄症状。根据意识模糊的原因，不同的治疗策略是合适的。在本文中，我们回顾了风险因素和评估工具，并介绍了针对老年癌症患者谵妄的干预措施。由于对老年癌症患者谵妄的研究较少，因此确定了未来的研究领域。
